GlassScriptPhysician profile
James Y Kim
NPI 1871256792
$2,988.28
in general payments reported to CMS, 2019-2025
22 companies · $511 in 2025
The $511 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $19.34 · 2022: $966 · 2023: $1,074 · 2024: $418 · 2025: $511.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,003.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,002.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $578.41 | 2022-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Pascal |
| Janssen Pharmaceuticals, INC | $571.46 | 2022-2024 | Xarelto |
| Novo Nordisk INC | $268.64 | 2022-2024 | Ozempic, Rybelsus |
| Novartis Pharmaceuticals Corporation | $235.00 | 2022-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $188.58 | 2022-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $179.70 | 2023 | Farxiga, Brilinta |
| Abbvie INC. | $156.81 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $129.21 | 2023 | Jardiance |
| Janssen Scientific Affairs, LLC | $102.62 | 2022 | |
| Shockwave Medical, INC | $86.65 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $81.30 | 2024-2025 | Impella |
| Elutia, INC. | $77.56 | 2022-2023 | |
| Boston Scientific Corporation | $73.86 | 2024 | Watchman Access System |
| Bayer Healthcare Pharmaceuticals INC. | $57.92 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $38.64 | 2023 | Camzyos |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $34.79 | 2022-2023 | Na |
| Pfizer INC. | $30.61 | 2025 | |
| Surmodics, INC. | $29.24 | 2023-2024 | Pounce Thrombectomy, Pounce Venous Thrombectomy System, Sublime Radial Access 018 Rx Pta Dilatation Catheter |
| Lantheus Medical Imaging, INC. | $21.68 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $19.34 | 2021 | |
| Chiesi USA, INC. | $13.22 | 2023 | Cleviprex, Kengreal |
| Cvrx, INC. | $13.04 | 2025 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.